Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 8086
Gene Symbol: AAAS
AAAS
0.010 GeneticVariation phenotype BEFREE Myoclonus and generalized digestive dysmotility in triple A syndrome with AAAS gene mutation. 15022193 2004
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.010 GeneticVariation phenotype BEFREE We used electrophysiological methods to study the hyperkinetic movement disorders in a pallido-ponto-nigral degeneration (PPND) family, which harbors the N279K tau gene mutation.Our purpose was to: (1). characterize the tremor patterns, (2). characterize the myoclonus physiology, (3). determine whether electrophysiology can detect abnormalities in asymptomatic cases. 12573870 2003
Entrez Id: 5286
Gene Symbol: PIK3C2A
PIK3C2A
0.010 Biomarker phenotype BEFREE The patient demonstrated generalized prolonged myoclonus severe enough to produce temperatures of 41.4 degrees C and CPK elevations to 7281 U/l. 12860512 2003
Entrez Id: 6948
Gene Symbol: TCN2
TCN2
0.010 GeneticVariation phenotype BEFREE Temporary myoclonus with treatment of congenital transcobalamin 2 deficiency. 11182287 2001
Entrez Id: 1557
Gene Symbol: CYP2C19
CYP2C19
0.010 GeneticVariation phenotype BEFREE Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors. 9395157 1997
Entrez Id: 7349
Gene Symbol: UCN
UCN
0.010 GeneticVariation phenotype BEFREE Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. 7581383 1995
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.010 Biomarker phenotype BEFREE Comparisons also suggested several ostensible phenotypic variants in 14qFAD: (1) In two 14q-linked kindreds (SNW/FAD3, FAD1), affected individuals in some instances were noted to survive to age 70 or beyond and the mean age at onset (> 49 years) in these two kindreds was somewhat higher than in their five 14qFAD counterparts (< 48 years in each); (2) in the SNW/FAD3 kindred, seizures and myoclonus were absent in all 10 subjects examined; and (3) cerebellar amyloid plaques were variably present within and among several 14qFAD kindreds. 8080245 1994
Entrez Id: 80308
Gene Symbol: FLAD1
FLAD1
0.010 Biomarker phenotype BEFREE Comparisons also suggested several ostensible phenotypic variants in 14qFAD: (1) In two 14q-linked kindreds (SNW/FAD3, FAD1), affected individuals in some instances were noted to survive to age 70 or beyond and the mean age at onset (> 49 years) in these two kindreds was somewhat higher than in their five 14qFAD counterparts (< 48 years in each); (2) in the SNW/FAD3 kindred, seizures and myoclonus were absent in all 10 subjects examined; and (3) cerebellar amyloid plaques were variably present within and among several 14qFAD kindreds. 8080245 1994
Entrez Id: 2643
Gene Symbol: GCH1
GCH1
0.020 Biomarker phenotype BEFREE In the combined forms, dystonia is accompanied by parkinsonism (GCH1/DYT5a; TH/DYT5b; ATP1A3/DYT12; TAF1/DYT3) or myoclonus (SGCE/DYT11). 24262166 2014
Entrez Id: 1861
Gene Symbol: TOR1A
TOR1A
0.020 GeneticVariation phenotype BEFREE Inherited dystonia designated by DYT locus symbols can be separated into three broad phenotypic categories: primary torsion dystonia (PTD), where dystonia is the only clinical sign (except for tremor) (DYT1, 2, 4, 6, 7, 13, 17, and 21); dystonia plus loci, where other phenotypes in addition to dystonia, including parkinsonism or myoclonus, are present (DYT3, 5/14, 11, 12, 15, and 16); and paroxysmal forms of dystonia/dyskinesia (DYT8, 9, 10, 18, 19, and 20). 22266882 2011
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.020 Biomarker phenotype BEFREE We suspected that myoclonus was due to dextromethorphan-related symptoms induced by CYP2D6, which primarily metabolizes dextromethorphan. 21228393 2011
Entrez Id: 1861
Gene Symbol: TOR1A
TOR1A
0.020 GeneticVariation phenotype LHGDN Stiff child syndrome with mutation of DYT1 gene. 16275837 2005
Entrez Id: 2643
Gene Symbol: GCH1
GCH1
0.020 Biomarker phenotype BEFREE The dystonia-plus group is defined by the association of parkinsonism (dopa-responsive-dystonia and rapid-onset dystonia-parkinsonism) or myoclonus (myoclonus-dystonia). 14628853 2003
Entrez Id: 1565
Gene Symbol: CYP2D6
CYP2D6
0.020 GeneticVariation phenotype BEFREE Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors. 9395157 1997
Entrez Id: 348
Gene Symbol: APOE
APOE
0.030 GeneticVariation phenotype BEFREE The rare presence of frontal lobe characteristics was associated with a younger age of onset, an increased incidence of myoclonus at presentation, a positive family history but not with possession of APOE epsilon4 allele. 17941342 2007
Entrez Id: 348
Gene Symbol: APOE
APOE
0.030 Biomarker phenotype BEFREE Because the decline in mental ability as well as the development of myoclonus and extrapyramidal signs are consistent manifestations of disease progression, our results imply that APOE epsilon4 is associated with a less aggressive form of AD. 9153523 1997
Entrez Id: 348
Gene Symbol: APOE
APOE
0.030 Biomarker phenotype BEFREE We have studied the relationship between the apolipoprotein E gene (APOE) and the development of myoclonus, tremors, rigidity and seizures in 168 patients with probable early-onset Alzheimer's disease (AD). 8803820 1996
Entrez Id: 26999
Gene Symbol: CYFIP2
CYFIP2
0.100 Biomarker phenotype HPO
Entrez Id: 1201
Gene Symbol: CLN3
CLN3
0.100 Biomarker phenotype HPO
Entrez Id: 284111
Gene Symbol: SLC13A5
SLC13A5
0.100 Biomarker phenotype HPO
Entrez Id: 116150
Gene Symbol: NUS1
NUS1
0.100 Biomarker phenotype HPO
Entrez Id: 132158
Gene Symbol: GLYCTK
GLYCTK
0.100 Biomarker phenotype HPO
Entrez Id: 5805
Gene Symbol: PTS
PTS
0.100 Biomarker phenotype HPO
Entrez Id: 51741
Gene Symbol: WWOX
WWOX
0.100 Biomarker phenotype HPO
Entrez Id: 51412
Gene Symbol: ACTL6B
ACTL6B
0.100 Biomarker phenotype HPO